Key result
While understanding of hibernation pathophysiology has improved dramatically, the clinical utility of identifying and targeting hibernation in ischemic heart failure remains unclear.
Answers are grounded in this paper and cite their sources.
This review highlights that while advanced imaging can identify hibernating myocardium, the clinical utility of viability testing to guide revascularization, especially in acute decompensated heart failure, remains uncertain.
PURPOSE OF REVIEW: Hibernation is an important and reversible cause of myocardial dysfunction in ischaemic heart failure. RECENT FINDINGS: Hibernation is an adaptive process that promotes myocyte survival over maintaining contractile function. It is innate to mammalian physiology, sharing features with physiological hibernation in other species. Advanced imaging methods have reasonable accuracy in identifying hibernating myocardium. Novel superior hybrid methods may provide diagnostic potential. New evidence supports the role of surgical revascularisation in ischaemic heart failure, but the role of viability tests in planning such procedures remains unclear. Research to date has exclusively involved patients with ambulatory heart failure: Investigating the role of hibernation in ADHF is a key avenue for the future. Whilst our understanding of hibernation pathophysiology has improved dramatically, the clinical utility of identifying and targeting hibernation remains unclear.
No takes yet. Share an insight, caveat, or question.
Ryan et al. (2018) conducted a review in Ischaemic heart failure and hibernating myocardium. Revascularization and viability testing vs. Medical therapy was evaluated. While understanding of hibernation pathophysiology has improved dramatically, the clinical utility of identifying and targeting hibernation in ischemic heart failure remains unclear.
Synapse has enriched 10 related papers. Consider them for comparative context: